Clinical Trials
- Digestive System
test
- Ages18 years - 75 years
- GenderBoth
- Digestive System
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Ages12 years - 75 years
- GenderBoth
- Endocrine System, Genetics
VX-121 Combination Therapy in Subjects With Cystic Fibrosis VX20-121-103
- Ages12 years and older
- GenderBoth
- Digestive System
test
- Ages18 years - 75 years
- GenderBoth
- Hepatitis, HIV/AIDS, Immune System, Infectious Disease
Screening In Anticipation of Future Research
- Ages2 years - 17 years
- GenderBoth
- Digestive System
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)
- Ages60 years - 84 years
- GenderBoth
- Diabetes
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)
- Ages8 years - 17 years
- GenderBoth
- Liver
test
- Ages18 years and older
- GenderBoth